Yorvipath 73362-0100-01
Generic: Palopegteriparatide
- Manufacturer
- Ascendis Pharma, Endocrinology, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 9, 2024
- Listing Expires
- December 31, 2027
- Application
- NDA216490
Need to source Yorvipath? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Palopegteriparatide | 168 ug/.56mL |
Drug Class
Parathyroid Hormone Analog [EPC]Parathyroid Hormone [CS]
Selected Package
73362-0100-01Selected2 BOX in 1 CARTON (73362-100-01) / 1 SYRINGE in 1 BOX (73362-100-02) / 1 CARTRIDGE in 1 SYRINGE (73362-100-03) / .56 mL in 1 CARTRIDGE